Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
REV Group | REVG | Nov 11, 2024 | 30.80 | +2.80 |
Revance Therapeutics | RVNC | Nov 11, 2024 | 3.45 | -6.76 |
Revelation Biosciences | REVB | Nov 11, 2024 | 1.04 | +26.83 |
Revenueshares Largecap | RWL | Nov 11, 2024 | 102.69 | +0.67 |
Revenueshares Midcap | RWK | Nov 11, 2024 | 123.18 | +0.84 |
Revenueshares Smallcap | RWJ | Nov 11, 2024 | 48.71 | +1.56 |
Revenueshares Ultra Dividend Fund | RDIV | Nov 11, 2024 | 51.35 | +1.24 |
Reviva Pharmaceuticals | RVPH | Nov 11, 2024 | 1.00 | +8.64 |
Revolution Medicines | RVMD | Nov 11, 2024 | 60.60 | +0.26 |
Revolve Group A | RVLV | Nov 11, 2024 | 33.57 | +6.67 |
Revvity | RVTY | Nov 11, 2024 | 120.64 | -1.49 |
REX American Resources | REX | Nov 11, 2024 | 49.04 | +1.11 |
Rexford Industrial Realty | REXR | Nov 11, 2024 | 42.76 | -0.81 |
Rexford Industrial Realty B Pref | REXR-B | Nov 11, 2024 | 23.15 | +0.22 |
Rexford Industrial Realty C Pref | REXR-C | Nov 11, 2024 | 23.04 | +0.83 |
Reynolds Consumer Products | REYN | Nov 11, 2024 | 27.55 | +0.40 |
Rezolute | RZLT | Nov 11, 2024 | 5.96 | +6.81 |
Rezolve AI Limited - Ordinary Shares | RZLV | Nov 11, 2024 | 4.31 | 0.00 |
RF Acquisition A | RFAC | Nov 11, 2024 | 11.46 | +0.17 |
RF Acquisition Corp II | RFAIU | Nov 11, 2024 | 10.25 | -2.38 |
RF Acquisition II | RFAI | Nov 11, 2024 | 10.25 | +0.49 |
RF Industries | RFIL | Nov 11, 2024 | 4.02 | -1.95 |
RGC Resources | RGCO | Nov 11, 2024 | 22.22 | -0.49 |
RH | RH | Nov 11, 2024 | 329.94 | -0.96 |
Rhinebeck Bancorp | RBKB | Nov 11, 2024 | 9.52 | +1.82 |
Rhythm Pharmaceuticals | RYTM | Nov 11, 2024 | 65.58 | -2.60 |
Ribbon Communications | RBBN | Nov 11, 2024 | 4.26 | +2.16 |
Richardson Electronics | RELL | Nov 11, 2024 | 14.48 | -1.16 |
Richmond Mutual Bank | RMBI | Nov 11, 2024 | 13.03 | +0.23 |
Richtech Robotics | RR | Nov 11, 2024 | 0.64 | +4.13 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.